For 10% of colorectal cancer patients, hereditary factors play a role, with higher percentages among younger patients.
In 2023, Jill Martin took a test that changed her life. She underwent genetic testing for breast cancer and learned she had a BRCA2 mutation, which increases one’s risk of developing breast and other ...
A genetic risk score could one day guide more personalized treatment for high-risk women, while sparing low-risk women from unnecessary procedures. A new genetic analysis could help predict whether ...
A doctor and public health expert explains why the new federal guidelines expanding cervical cancer screening to at-home ...
Regeneron Pharmaceuticals said Monday it will buy genetic testing company 23andMe out of bankruptcy for $256 million, a deal that provides the US biotech company with data on millions of clients.
Thousands of women with a cancer-causing genetic mutation are facing an agonising wait for a mastectomy, due to a backlog ...